Cargando…

MRI Virtual Biopsy of T2 Hyperintense Breast Lesions

A wide variety of benign and malignant breast processes may generate hyperintense signal at T2-weighted magnetic resonance imaging (MRI). MRI has been traditionally used in the pre-treatment planning of breast cancer, in assessing treatment response and detecting recurrence. In this comprehensive re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Swati, Nwachukwu, Chidi, Wieseler, Carissa, Elsherif, Sherif, Letter, Haley, Sharma, Smita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053438/
https://www.ncbi.nlm.nih.gov/pubmed/33880243
http://dx.doi.org/10.25259/JCIS_42_2021
_version_ 1783680120693719040
author Sharma, Swati
Nwachukwu, Chidi
Wieseler, Carissa
Elsherif, Sherif
Letter, Haley
Sharma, Smita
author_facet Sharma, Swati
Nwachukwu, Chidi
Wieseler, Carissa
Elsherif, Sherif
Letter, Haley
Sharma, Smita
author_sort Sharma, Swati
collection PubMed
description A wide variety of benign and malignant breast processes may generate hyperintense signal at T2-weighted magnetic resonance imaging (MRI). MRI has been traditionally used in the pre-treatment planning of breast cancer, in assessing treatment response and detecting recurrence. In this comprehensive review, we describe and illustrate the MRI features of a few common and uncommon T2 hyperintense breast lesions, with an emphasis on MRI features that help to characterize lesions based on morphological features, specific appearances on T1-and T2-weighted imaging, and enhancement characteristics on the dynamic post-contrast phase that are either diagnostic or aid in narrowing the differential diagnosis.
format Online
Article
Text
id pubmed-8053438
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Scientific Scholar
record_format MEDLINE/PubMed
spelling pubmed-80534382021-04-19 MRI Virtual Biopsy of T2 Hyperintense Breast Lesions Sharma, Swati Nwachukwu, Chidi Wieseler, Carissa Elsherif, Sherif Letter, Haley Sharma, Smita J Clin Imaging Sci Review Article A wide variety of benign and malignant breast processes may generate hyperintense signal at T2-weighted magnetic resonance imaging (MRI). MRI has been traditionally used in the pre-treatment planning of breast cancer, in assessing treatment response and detecting recurrence. In this comprehensive review, we describe and illustrate the MRI features of a few common and uncommon T2 hyperintense breast lesions, with an emphasis on MRI features that help to characterize lesions based on morphological features, specific appearances on T1-and T2-weighted imaging, and enhancement characteristics on the dynamic post-contrast phase that are either diagnostic or aid in narrowing the differential diagnosis. Scientific Scholar 2021-04-01 /pmc/articles/PMC8053438/ /pubmed/33880243 http://dx.doi.org/10.25259/JCIS_42_2021 Text en © 2021 Published by Scientific Scholar on behalf of Journal of Clinical Imaging Science https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Sharma, Swati
Nwachukwu, Chidi
Wieseler, Carissa
Elsherif, Sherif
Letter, Haley
Sharma, Smita
MRI Virtual Biopsy of T2 Hyperintense Breast Lesions
title MRI Virtual Biopsy of T2 Hyperintense Breast Lesions
title_full MRI Virtual Biopsy of T2 Hyperintense Breast Lesions
title_fullStr MRI Virtual Biopsy of T2 Hyperintense Breast Lesions
title_full_unstemmed MRI Virtual Biopsy of T2 Hyperintense Breast Lesions
title_short MRI Virtual Biopsy of T2 Hyperintense Breast Lesions
title_sort mri virtual biopsy of t2 hyperintense breast lesions
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053438/
https://www.ncbi.nlm.nih.gov/pubmed/33880243
http://dx.doi.org/10.25259/JCIS_42_2021
work_keys_str_mv AT sharmaswati mrivirtualbiopsyoft2hyperintensebreastlesions
AT nwachukwuchidi mrivirtualbiopsyoft2hyperintensebreastlesions
AT wieselercarissa mrivirtualbiopsyoft2hyperintensebreastlesions
AT elsherifsherif mrivirtualbiopsyoft2hyperintensebreastlesions
AT letterhaley mrivirtualbiopsyoft2hyperintensebreastlesions
AT sharmasmita mrivirtualbiopsyoft2hyperintensebreastlesions